Evidence map›Paper›PMID 33961290›Full record

ArticleFEBS letters2021

Serum levels of the IgA isotype switch factor TGF-β1 are elevated in patients with COVID-19.

Er-Yi Wang, Hao Chen, Bao-Qing Sun, Hui Wang, Hui-Qi Qu, Yichuan Liu, Xi-Zhuo Sun, Jingchun Qu, Zhang-Fu Fang, Lifeng Tian and 4 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in FEBS letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Cytokines and microRNAs in SARS-CoV-2: What do we know?Molecular therapy. Nucleic acids · 2022
    Review
  17. Review
  18. New Clinical Phenotype of the Post-Covid Syndrome: Fibromyalgia and Joint Hypermobility Condition.Pathophysiology : the official journal of the International Society for Pathophysiology · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Er-Yi WangShenzhen Key Laboratory of Allergy & Immunology, State Key Laboratory of Respiratory Disease for Allergy at Shenzhen University, Shenzhen University School of Medicine, China.
Hao ChenDepartment of Allergy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Bao-Qing SunState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, China.
Hui WangDepartment of Medical Laboratory, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hui-Qi QuCenter for Applied Genomics, The Children's Hospital of Philadelphia, PA, USA.ORCID 0000-0001-9317-4488
Yichuan LiuCenter for Applied Genomics, The Children's Hospital of Philadelphia, PA, USA.ORCID 0000-0003-2023-072X
Xi-Zhuo SunDepartment of Respirology & Allergy, Third Affiliated Hospital of Shenzhen University, China.
Jingchun QuCenter for Applied Genomics, The Children's Hospital of Philadelphia, PA, USA.ORCID 0000-0003-1974-2496
Zhang-Fu FangShenzhen Key Laboratory of Allergy & Immunology, State Key Laboratory of Respiratory Disease for Allergy at Shenzhen University, Shenzhen University School of Medicine, China.
Lifeng TianCenter for Applied Genomics, The Children's Hospital of Philadelphia, PA, USA.
Yi-Feng ZengState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, China.
Shau-Ku HuangShenzhen Key Laboratory of Allergy & Immunology, State Key Laboratory of Respiratory Disease for Allergy at Shenzhen University, Shenzhen University School of Medicine, China.
Hakon HakonarsonCenter for Applied Genomics, The Children's Hospital of Philadelphia, PA, USA.
Zhi-Gang LiuShenzhen Key Laboratory of Allergy & Immunology, State Key Laboratory of Respiratory Disease for Allergy at Shenzhen University, Shenzhen University School of Medicine, China.
Children's Hospital of Philadelphia · USShenzhen University · CNFirst Affiliated Hospital of Guangzhou Medical University · CNCentral Hospital of Wuhan · CNNational Health Research Institutes · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously observed enhanced immunoglobulin A (IgA) responses in severe COVID-19, which might confer damaging effects. Given the important role of IgA in immune and inflammatory responses, the aim of this study was to investigate the dynamic response of the IgA isotype switch factor TGF-β1 in COVID-19 patients. We observed, in a total of 153 COVID-19 patients, that the serum levels of TGF-β1 were increased significantly at the early and middle stages of COVID-19, and correlated with the levels of SARS-CoV-2-specific IgA, as well as with the APACHE II score in patients with severe disease. In view of the genetic association of the TGF-β1 activator THBS3 with severe COVID-19 identified by the COVID-19 Host Genetics Initiative, this study suggests TGF-β1 may play a key role in COVID-19.

Indexed as

AdultAgedAntibodies, ViralAPACHECOVID-19FemaleHumansImmunoglobulin AMaleMiddle AgedPolymorphism, Single NucleotideSARS-CoV-2ThrombospondinsTransforming Growth Factor beta1Antibodies, ViralImmunoglobulin ATGFB1 protein, humanthrombospondin 3ThrombospondinsTransforming Growth Factor beta1COVID-19IgASARS-CoV-2TGF-β1

Identifiers

PMID33961290
PMCPMC8209884
OpenAlexW3159042666

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.